Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ALT
#2659
Altimmune, Inc. Common Stock
4.3
1
-4.01%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-4.01%
Monthly Change
-27.81%
6 month change
+14.02%
Year Change
-31.04%
Previous Close
4.4
9
Open
4.3
1
Bid
Ask
Low
4.3
1
High
4.3
1
Volume
103
Markets
US Stock Market
Healthcare
ALT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
AIM Smarter, Christopher Young’ı ticari direktör olarak atadı
AIM Smarter appoints Christopher Young as chief commercial officer
Obesity stocks slump on Novo’s underwhelming 2026 sales forecast
Obesity stocks slump on Novo's underwhelming 2026 sales forecast
Novo Nordisk hisseleri zayıf 2026 satış görünümü nedeniyle düşüşte
Novo Nordisk hisseleri zayıf 2026 satış beklentisiyle sert düştü
Novo Nordisk shares plunge on weak 2026 sales outlook
Altimmune 75 milyon dolarlık kayıtlı doğrudan teklifini tamamladı
Altimmune closes $75 million registered direct offering
Altimmune: Why Breakthrough Status Isn't A 'Buy' Signal Just Yet (NASDAQ:ALT)
Altimmune (ALT) Shares Slide On $75 Million Stock Offering - Altimmune (NASDAQ:ALT)
Altimmune hisseleri 75 milyon dolarlık doğrudan satış duyurusunun ardından düştü